1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: November 16-22, 2025
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: November 16-22, 2025

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 11/17/2025
Location: Washington, DC
Subject: Food Allergy Fund Leadership Forum; Speaker: Keynote Address
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 11/17/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Susan Collins, (R-ME)

Event Date: 11/17/2025
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator John Hoeven, (R-ND)

Event Date: 11/18/2025
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Eric Burlison, (R-MO)

Event Date: 11/21/2025
Location: Washington, DC
Subject: Improving the Healthfulness of the U.S. Food Supply
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Center for Science in the Public Interest representatives

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

Event Date: 11/17/2025
Location: New York, NY
Subject: Women's Health Nexus; Speaker: Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 11/19/2025
Location: Washington, DC
Subject: Make America Healthy Again (MAHA) Institute, Reclaiming Science: The People's NIH; Panelist
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

No Significant Event

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 11/20/2025
Location: Silver Spring, MD
Subject: Collaboration Opportunities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Formation Bio representatives

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Richard Pazdur, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

Event Date: 11/18/2025
Location: College Park, MD
Subject: Items of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: American Veterinary Medical Association (AVMA) representatives

Back to Top